Treatment of malignant pheochromocytoma/paraganglioma with cyclophosphamide, vincristine, and dacarbazine

A long‐term follow‐up was conducted of 18 patients with a diagnosis of pheochromocytoma/paraganglioma treated with a combination of cyclophosphamide, vincristine, and dacarbazine (CVD).

[1]  K. Svärdsudd,et al.  Pheochromocytoma in Sweden 1958-1981. An analysis of the National Cancer Registry Data. , 2009, Acta medica Scandinavica.

[2]  K. Pacak.  Preoperative management of the pheochromocytoma patient. , 2007, The Journal of clinical endocrinology and metabolism.

[3]  K. Pacak,et al.  Clinical presentations, biochemical phenotypes, and genotype-phenotype correlations in patients with succinate dehydrogenase subunit B-associated pheochromocytomas and paragangliomas. , 2007, The Journal of clinical endocrinology and metabolism.

[4]  W. Linehan,et al.  High frequency of SDHB germline mutations in patients with malignant catecholamine-producing paragangliomas: implications for genetic testing. , 2006, The Journal of clinical endocrinology and metabolism.

[5]  K. Byth,et al.  Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes. , 2006, The Journal of clinical endocrinology and metabolism.

[6]  Jeffrey W. Clark,et al.  Phase II study of temozolomide and thalidomide in patients with metastatic neuroendocrine tumors. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  S. Richard,et al.  Genetic testing in pheochromocytoma or functional paraganglioma. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  I. Gill,et al.  Comparison of CT findings in symptomatic and incidentally discovered pheochromocytomas. , 2005, AJR. American journal of roentgenology.

[9]  Karel Pacak,et al.  Phaeochromocytoma , 2005, The Lancet.

[10]  W. Mcdougal.  Pheochromocytoma: state-of-the-art and future prospects. , 2005, The Journal of urology.

[11]  M. Dobrzyńska.  The effects in mice of combined treatments to X-rays and antineoplastic drugs in the Comet assay. , 2005, Toxicology.

[12]  David I. Smith,et al.  Malignant pheochromocytoma: current status and initiatives for future progress. , 2004, Endocrine-related cancer.

[13]  C. Eng,et al.  Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. , 2004, JAMA.

[14]  S. Roman,et al.  Pheochromocytoma and functional paraganglioma , 2005, Current opinion in oncology.

[15]  P. Rustin,et al.  Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas. , 2003, Cancer research.

[16]  M. Nakane,et al.  Successful treatment of malignant pheochromocytoma with combination chemotherapy containing anthracycline. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[17]  A. Höög,et al.  The management of benign and malignant pheochromocytoma and abdominal paraganglioma. , 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[18]  Julian A. Smith.  Sabiston. Textbook of Surgery: The Biological Basis of Modern Surgical Practice , 2002 .

[19]  A. M. Cotlar.  Sabiston Textbook of Surgery: The Biological Basis of Modern Surgical Practice , 2001 .

[20]  G. Chatellier,et al.  Factors associated with perioperative morbidity and mortality in patients with pheochromocytoma: analysis of 165 operations at a single center. , 2001, The Journal of clinical endocrinology and metabolism.

[21]  R. Herwig,et al.  Clinical differences between benign and malignant pheochromocytomas. , 2001, Endocrine journal.

[22]  W. Linehan,et al.  Recent Advances in Genetics, Diagnosis, Localization, and Treatment of Pheochromocytoma , 2001, Annals of Internal Medicine.

[23]  M. Roden,et al.  Diagnostic efficacy of unconjugated plasma metanephrines for the detection of pheochromocytoma. , 2000, Archives of internal medicine.

[24]  M. Mannelli,et al.  Pheochromocytoma in Italy: a multicentric retrospective study. , 1999, European journal of endocrinology.

[25]  A. Charpentier,et al.  A malignant primary cardiac pheochromocytoma. , 1999, The Annals of thoracic surgery.

[26]  N. Abumrad,et al.  Clinical experience over 48 years with pheochromocytoma. , 1999, Annals of surgery.

[27]  D. Hauri,et al.  Pheochromocytomas: can malignant potential be predicted? , 1999, Urology.

[28]  D. Schroeder,et al.  Perianesthetic Risks and Outcomes of Pheochromocytoma and Paraganglioma Resection , 1998, Anesthesia and analgesia.

[29]  G. Chatellier,et al.  Tumor recurrence and hypertension persistence after successful pheochromocytoma operation. , 1997, Hypertension.

[30]  E. Newlands,et al.  In vitro evaluation of temozolomide combined with X-irradiation , 1997, Anti-cancer drugs.

[31]  J. Carney,et al.  Clinical Spectrum and Outcome of Functional Extraadrenal Paraganglioma , 1996, World Journal of Surgery.

[32]  R. Kiss,et al.  Cross resistance and collateral sensitivity between cytotoxic drugs and radiation in two human bladder cell lines. , 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[33]  W. Young,et al.  Spells: in search of a cause. , 1995, Mayo Clinic proceedings.

[34]  R. García-mayor,et al.  Incidence of pheochromocytoma in South Galicia, Spain , 1994, Journal of internal medicine.

[35]  E. Bravo,et al.  Evolving concepts in the pathophysiology, diagnosis, and treatment of pheochromocytoma. , 1994, Endocrine reviews.

[36]  M. Schlumberger,et al.  Malignant pheochromocytoma: Clinical, biological, histologic and therapeutic data in a series of 20 patients with distant metastases , 1992, Journal of endocrinological investigation.

[37]  E. Bravo.  Pheochromocytoma: new concepts and future trends. , 1991, Kidney international.

[38]  S. Strandgaard,et al.  The incidence rate of phaeochromocytoma and Conn's syndrome in Denmark, 1977-1981. , 1988, Journal of human hypertension.

[39]  E. Gelmann,et al.  Malignant pheochromocytoma: effective treatment with a combination of cyclophosphamide, vincristine, and dacarbazine. , 1988, Annals of internal medicine.

[40]  K. Kato,et al.  Production of the alpha subunit of guanine nucleotide-binding protein GO by neuroendocrine tumors. , 1987, Cancer research.

[41]  A. Nagasaka,et al.  Production of the α Subunit of Guanine Nucleotide-binding Protein Go by Neuroendocrine Tumors , 1987 .

[42]  D. Perry-Keene,et al.  Phaeochromocytoma in Queensland--1970-83. , 1985, The Australian and New Zealand journal of surgery.

[43]  L. Kurland,et al.  Occurrence of pheochromocytoma in Rochester, Minnesota, 1950 through 1979. , 1983, Mayo Clinic proceedings.

[44]  J R Anderson,et al.  Analysis of survival by tumor response. , 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[45]  J. Oates,et al.  Clinical experience with malignant pheochromocytomas. , 1982, Surgery, gynecology & obstetrics.

[46]  P. Sheedy,et al.  Pheochromocytoma: current status and changing trends. , 1982, Surgery.

[47]  S. Sheps,et al.  CURRENT MANAGEMENT OF PHEOCHROMOCYTOMA , 1975 .

[48]  M. Voorhess.  The catecholamines in tumor and urine from patients with neuroblastoma, ganglioneuroblastoma and pheochromocytoma. , 1968, Journal of pediatric surgery.

[49]  N. Mantel.  Evaluation of survival data and two new rank order statistics arising in its consideration. , 1966, Cancer chemotherapy reports.

[50]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[51]  G. Wampler,et al.  Case report of metastatic familial pheochromocytoma treated with cisplatin and 5-fluorouracil , 2004, Cancer Chemotherapy and Pharmacology.

[52]  G. Arnaldi,et al.  Adrenal incidentaloma. , 2000, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[53]  H. Black,et al.  A simplified diagnostic approach to pheochromocytoma. A review of the literature and report of one institution's experience. , 1991, Medicine.

[54]  H. J. Lewi,et al.  Malignant phaeochromocytoma. , 1985, British journal of urology.